Weekly Digest – July 2025 Weekly Digest – July 2025 04 July 2025: InnoCare announces approval of clinical trial of a novel ADC ICP-B794 in China InnoCare Pharma received IND approval from China’s NMPA to begin clinical trials for ICP-B794, […]
Weekly Digest – July 2025 Weekly Digest – July 2025 01 July 2025: Iksuda Therapeutics receives FDA IND clearance for IKS014 The U.S. FDA has cleared Iksuda Therapeutics’ IND application for IKS014, a HER2-targeting ADC, enabling expansion of its ongoing […]
Weekly Digest – July 2025 Weekly Digest – July 2025 01 July 2025: Huadong Medicine’s first-in-class ADC HDM2012 gains FDA Phase I trial clearance Huadong Medicine received FDA clearance to begin a Phase I clinical trial in the U.S. for […]
